Year: 2007

Following Dura Pharmaceuticals, Inc., v. Broude, 544 U.S. 356 (2005), securities law plaintiffs can no longer simply plead “fraud on the market” to link the claimed fraud to the economic injury. While such an allegation continues to suffice as to …

LIABILITY IN SECURITIES FRAUD ACTIONS: Part XX: Theories of Proof Under Dura. Read More »